Member Exclusive

Target identified which could open the door to personalized treatment for heart failure

An enzyme which cross-links collagen has been identified as a target for personalized treatment in heart failure. The enzyme, termed Lysyl oxidase-like 2, produces fibrosis of the cardiac muscle, which stimulates the development of heart failure when in excess.

Go to the profile of MedChemNet
Feb 08, 2017
0
0

Please sign in or register for FREE

Register to MedChemNet – the medicinal chemistry network

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.

Register

No comments yet.